COST-EFFECTIVENESS AND PUBLIC HEALTH IMPACT OF A NINE-VALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN UKRAINE

被引：0
|
作者：
Ugrekhelidze, D. [1 ]
Pavelyev, A. [2 ]
Daniels, V [3 ]
Grubaia, A. [4 ]
Fedotova, K. [4 ]
机构：
[1] MSD, Zurich, Switzerland
[2] Merck & Co Inc, Rahway, NJ USA
[3] Merck & Co Inc, Rahway, NJ USA
[4] MSD, Kiev, Ukraine
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE596
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [31] Parental Attitudes and Beliefs Regarding the Nine-Valent Human Papillomavirus Vaccine
    Fontenot, Holly B.
    Domush, Vanessa
    Zimet, Gregory D.
    JOURNAL OF ADOLESCENT HEALTH, 2015, 57 (06) : 595 - 600
  • [32] An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany
    Largeron, Nathalie
    Petry, Karl Ulrich
    Jacob, Jorge
    Bianic, Florence
    Anger, Delphine
    Uhart, Mathieu
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (01) : 85 - 98
  • [33] Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
    de Kok, Inge M. C. M.
    van Ballegooijen, Marjolein
    Habbema, J. Dik F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (15): : 1083 - 1092
  • [34] Cost-effectiveness of human papillomavirus vaccination in the United States
    Chesson, Harrell W.
    Ekwueme, Donatus U.
    Saraiya, Mona
    Markowitz, Lauri E.
    EMERGING INFECTIOUS DISEASES, 2008, 14 (02) : 244 - 251
  • [35] Cost-effectiveness of human papillomavirus vaccination and screening in Spain
    Diaz, Mireia
    de Sanjose, Silvia
    Ortendahl, Jesse
    O'Shea, Meredith
    Goldie, Sue J.
    Bosch, F. Xavier
    Kim, Jane J.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (16) : 2973 - 2985
  • [36] RETRACTED: Impact and Cost-Effectiveness of Human Papillomavirus Vaccination Campaigns (Retracted Article)
    Portnoy, Allison
    Campos, Nicole G.
    Sy, Stephen
    Burger, Emily A.
    Cohen, Jamie
    Regan, Catherine
    Kim, Jane J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (01) : 22 - 30
  • [37] THE PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE VACCINATION IN ESTONIA
    Posiuniene, I
    Saar, I
    Van de Velde, N.
    VALUE IN HEALTH, 2015, 18 (07) : A583 - A583
  • [38] PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF MALARIA ROUTINE VACCINATION IN INFANTS
    Sauboin, C.
    Sicuri, E.
    Van Bellinghen, L.
    Van de Velde, N.
    Van Vlaenderen, I
    VALUE IN HEALTH, 2015, 18 (07) : A338 - A339
  • [39] Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands
    Simons, Joost J. M.
    Vida, Nora
    Westra, Tjalke A.
    Postma, Maarten J.
    VACCINE, 2020, 38 (30) : 4687 - 4694
  • [40] Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the Netherlands
    Simons, Joost J. M.
    Westra, Tjalke A.
    Postma, Maarten J.
    PREVENTIVE MEDICINE REPORTS, 2022, 28
12345